|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.15 USD | +2.10% |
|
+6.65% | -28.02% |
| 10/06 | EyePoint, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 11:20 AM | |
| 14/05 | EyePoint's late-stage eye drug trials to continue after safety panel review | RE |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EYEPOINT, INC. | Other Pharmaceuticals | +2.10% | +6.65% | -28.02% | +49.26% | +36.98% | 107.99Cr |  |  | |
- Stock Market
- Stocks
- EYPT Stock
- Charts EyePoint, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition